Bio Protocol vs Dai — how do they compare? Bio Protocol trades at Rp442.9 (market cap Rp1T, Rp162,69M 24h volume), while Dai trades at Rp17,251 (market cap Rp92,41T, Rp1,28T 24h volume). The key difference: Dai is far larger — about 92.4× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Dai's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Dai for 31 Days on average.
| BIO | DAI | |
|---|---|---|
Market Cap | Rp1T | Rp92,41T |
Volume (24h) | Rp162,69M | Rp1,28T |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 5,4B DAI |
Typical Hold Time | 18 Days | 31 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Dai maintains a substantial market cap of Rp92,41T with 5,4M tokens in circulation, indicating significant adoption as a stablecoin. The 31-day average hold time suggests stable usage patterns. Technical analysis shows consistent stability within its peg range, with trading volumes reflecting steady demand. Recent ecosystem developments include ongoing protocol optimizations to maintain the USD peg through collateralized debt positions.
Overall outlook remains stable given Dai's proven track record as a decentralized stablecoin. Key opportunities include continued DeFi adoption and cross-chain expansion. Major risks include regulatory scrutiny of stablecoins and potential collateral volatility. Investors should monitor MakerDAO governance decisions and overall DeFi market health.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →DAI is an Ethereum-based stablecoin managed by the Maker Protocol and MakerDAO. Its value is soft-pegged to the U.S. dollar and backed by various cryptocurrencies stored in smart contract vaults. DAI provides a decentralized way to hold a stable digital asset, with options like Multi-Collateral DAI for flexible backing and the DAI Savings Rate for earning interest.
Read more on DAI →